Effect of bacterial lipopolysaccharide on ischemic damage in the rat retina

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4604-4612

  Franco, Pablo J ^a   Fernandez, Diego C ^a,b   Sande, Pablo H ^a   Sarmiento, María I Keller ^a   Chianelli, Mónica ^a   Sáenz, Daniel A ^a   Rosenstein, Ruth E ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE MORÓN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; CITRULLINE; N (3 (AMINOMETHYL)BENZYL)ACETAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRORETINOGRAPHY; ENZYME ACTIVITY; EYE PROTECTION; HISTOLOGY; INTRAOCULAR PRESSURE; ISCHEMIC PRECONDITIONING; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RETINA ISCHEMIA; ANIMAL; INJECTION; METABOLISM; PATHOPHYSIOLOGY; RETINA BLOOD VESSEL; RETINA DISEASE; SALMONELLA TYPHIMURIUM; VITREOUS BODY; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; ENZYME INHIBITORS; GUANIDINES; INJECTIONS; ISCHEMIC PRECONDITIONING; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; REPERFUSION INJURY; RETINAL DISEASES; RETINAL VESSELS; SALMONELLA TYPHIMURIUM; VITREOUS BODY;

EID: 53449089581     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2054     Document Type: Article

References (57)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-1136.
2. Kitagawa K, Matsumoto M, Tagaya M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 1990;528(1):21-24. (Pubitemid 20292932)
3. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg. 2003;20(5):383-396. (Pubitemid 37116937)
4. Roth S, Li B, Rosenbaum PS, et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci. 1998;39(5):777-785. (Pubitemid 28207473)
5. Yu SY, Chiu JH, Yang SD, et al. Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats. J Surg Res. 2005;128(1):28-36. (Pubitemid 41188206)
6. Ravati A, Ahlemeyer B, Becker A, Krieglstein J. Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res. 2000;866(1-2):23-32. (Pubitemid 30313004)
7. Kwong JM, Lam TT, Caprioli J. Hyperthermic pre-conditioning protects retinal neurons from N-methyl-D-aspartate (NMDA)-induced apoptosis in rat. Brain Res. 2003;970(1-2):119-130. (Pubitemid 36423187)
8. Casson RJ, Wood JP, Melena J, Chidlow G, Osborne NN. The effect of ischemic preconditioning on light-induced photoreceptor injury. Invest Ophthalmol Vis Sci. 2003;44(3):1348-1354. (Pubitemid 36297859)
9. Liu C, Peng M, Laties AM, Wen R. Preconditioning with bright light evokes a protective response against light damage in the rat retina. J Neurosci. 1998;18(4):1337-1344. (Pubitemid 28082419)
10. Bush RA, Williams TP. The effect of unilateral optic nerve section on retinal light damage in rats. Exp Eye Res. 1991;52(2):139-153.
11. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 1997;748(1-2):267-270. (Pubitemid 27094913)
12. Dawson DA, Furuya K, Gotoh J, Nakao Y, Hallenbeck JM. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion. J Cereb Blood Flow Metab. 1999;19(6):616-623. (Pubitemid 30161213)
13. Rowland RT, Cleveland JC, Meng X, Ao L, Harken AH, Brown JM. A single endotoxin challenge induces delayed myocardial protection against infarction. J Surg Res. 1996;63(1):193-198. (Pubitemid 26197194)
14. Lastres-Becker I, Cartmell T, Molina-Holgado FJ. Endotoxin preconditioning protects neurons from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. J Neuroimmunol. 2006;173(1-2):108-116.
15. Rosenzweig HL, Minami M, Lessov NS, et al. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab. 2007;27(10):1663-1674. (Pubitemid 47476093)
16. Li B, Yang C, Rosenbaum DM, Roth S. Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp Eye Res. 2000;70(6):755-765. (Pubitemid 30671655)
17. Ettaiche M, Heurteaux C, Blondeau N, Borsotto M, Tinel N, Lazdunski M. ATP-sensitive potassium channels (K(ATP)) in retina: a key role for delayed ischemic tolerance. Brain Res. 2001;890(1):118-129. (Pubitemid 32119531)
18. Sakamoto K, Kuwagata M, Nakahara T, Ishii K. Late preconditioning in rat retina: involvement of adenosine and ATP-sensitive K(+) channel. Eur J Pharmacol. 2001;418(1-2):89-93. (Pubitemid 32378814)
19. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 1996;78(6):1100-1104. (Pubitemid 126425277)
20. Wiegand F, Liao W, Busch C, et al. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab. 1999;19(11):1229-1237. (Pubitemid 30176451)
21. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006;7(6):437-448.
22. Zhu Y, Ohlemiller KK, McMahan BK, Park TS, Gidday JM. Constitutive nitric oxide synthase activity is required to trigger ischemic tolerance in mouse retina. Exp Eye Res. 2006;82(1):153-163. (Pubitemid 43063406)
23. Sakamoto K, Yonoki Y, Kubota Y, et al. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina. Exp Eye Res. 2006;82(3):512-518. (Pubitemid 43140720)
24. Jacquemin E, de Kozak Y, Thillaye B, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest Ophthalmol Vis Sci. 1996;37(6):1187-1196. (Pubitemid 26164248)
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-275.
26. Kawano T, Kunz A, Abe T, et al. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite. J Cereb Blood Flow Metab. 2007;27(8):1453-1462.
27. Kobata A, Kotani T, Komatsu Y, Amagase K, Kato S, Takeuchi K. Dual action of nitric oxide in the pathogenesis of ischemia/reperfusion-induced mucosal injury in mouse stomach. Digestion. 2007;75(4):188-197. (Pubitemid 350202465)
28. Belforte N, Moreno MC, Cymeryng C, Bordone M, Keller Sarmiento MI, Rosenstein RE. Effect of ocular hypertension on retinal nitridergic pathway activity. Invest Ophthalmol Vis Sci. 2007;48(5):2127-2133. (Pubitemid 351261286)
29. Zhang C, Rosenbaum DM, Shaikh AR, et al. Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest Ophthalmol Vis Sci. 2002;43(9):3059-3066. (Pubitemid 34977060)
30. Toprak AB, Ozbilgin K, Toprak V, Tuglu I, Guler C. A histological analysis of the protective effect of ischemic preconditioning in the rat retina. Curr Eye Res. 2002;24(3):234-239. (Pubitemid 35216136)
31. Roth S, Dreixler JC, Shaikh AR, Lee KH, Bindokas V. Mitochondrial potassium ATP channels and retinal ischemic preconditioning. Invest Ophthalmol Vis Sci. 2006;47(5):2114-2124. (Pubitemid 46768296)
32. Hylkema HA. The role of the immune system in uveitis induced in animals. Doc Ophthalmol. 1988;70(4):339-351. (Pubitemid 19141713)
33. Smith JR, Hart PH, Williams KA. Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol. 1998;76(6):497-512.
34. Howes EL Jr, Cole PW, Cruse VK, Pollycove M. Quantitation of acute experimental ocular inflammation with 111indium-leukocytes. Invest Ophthalmol Vis Sci. 1988;29(3):429-436. (Pubitemid 18078039)
35. Cousins SW, Guss RB, Howes EL Jr, Rosenbaum JT. Endotoxin-induced uveitis in the rat: observations on altered vascular permeability, clinical findings, and histology. Exp Eye Res. 1984;39(5):665-676.
36. Green K, Paterson CA, Cheeks L, Slagle T, Jay WM, Aziz MZ. Ocular blood flow and vascular permeability in endotoxin-induced inflammation. Ophthalmic Res. 1990;22(5):287-294. (Pubitemid 20383300)
37. Rowland RT, Meng X, Cleveland JC Jr, Meldrum DR, Harken AH, Brown JM. LPS-induced delayed myocardial adaptation enhances acute preconditioning to optimize postischemic cardiac function. Am J Physiol. 1997;272:H2708-H2715. (Pubitemid 27300447)
38. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke. 2004;35(11):2576-2581. (Pubitemid 39458420)
39. Hashiguchi A, Yano S, Morioka M, et al. Up-regulation of endothelial nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab. 2004;24(3):271-279. (Pubitemid 38314583)
40. Gidday JM, Shah AR, Maceren RG, et al. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab. 1999;19(3):331-340.
41. Atochin DN, Clark J, Demchenko IT, Moskowitz MA, Huang PL. Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke. 2003;34(5):1299-1303. (Pubitemid 36547532)
42. Cho S, Park EM, Zhou P, Frys K, Ross ME, Iadecola C. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J Cereb Blood Flow Metab. 2005;25(4):493-501. (Pubitemid 40502999)
43. Misko TP, Moore WM, Kasten TP, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 1993;233(1):119-125. (Pubitemid 23091752)
44. Fedorov R, Hartmann E, Ghosh DK, Schlichting I. Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and Nomega-propyl-L-Arg for the inducible and neuronal isoforms. J Biol Chem. 2003;278(46):45818-45825. (Pubitemid 37432727)
45. Koga T, Koshiyama Y, Gotoh T, et al. Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. Exp Eye Res. 2002;75(6):659-667. (Pubitemid 36034630)
46. Szabó A, Farkas A, Vámos R, Bajor T, Hrabák A. The inhibition of retinal inducible nitric oxide synthase overexpression and the attenuation of experimental uveitis by anti-inflammatory drugs in rats. Inflamm Res. 2004;53(6):262-267. (Pubitemid 38797564)
47. Wang YP, Sato C, Mizoguchi K, Yamashita Y, Oe M, Maeta H. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res. 2002;56(1):33-42. (Pubitemid 35247800)
48. Sakamoto K, Yonoki Y, Kuwagata M, Saito M, Nakahara T, Ishii K. Histological protection against ischemia-reperfusion injury by early ischemic preconditioning in rat retina. Brain Res. 2004;1015(1-2):154-160. (Pubitemid 38829749)
49. Roth S. Endogenous neuroprotection in the retina. Brain Res Bull. 2004;62(6):461-466.
50. Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007;171(1):53-67. (Pubitemid 47339226)
51. Cuong DV, Kim N, Youm JB, et al. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts. Am J Physiol Heart Circ Physiol. 2006;290(5):H1808-H1817.
52. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 1996;36(18):2979-2994. (Pubitemid 26326608)
53. Hayashi A, Koroma BM, Imai K, de Juan E Jr. Increase of protein tyrosine phosphorylation in rat retina after ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 1996;37(11):2146-2156. (Pubitemid 26338763)
54. Szabo ME, Droy-Lefaix MT, Doly M, Carré C, Braquet P. Ischemia and reperfusion-induced histologic changes in the rat retina: demonstration of a free radical-mediated mechanism. Invest Ophthalmol Vis Sci. 1991;32(5):1471- 1478.
55. Ju WK, Kim KY, Park SJ, et al. Nitric oxide is involved in sustained and delayed cell death of rat retina following transient ischemia. Brain Res. 2000;881(2):231-236.
56. Kim IB, Kim KY, Joo CK, et al. Reaction of Müller cells after increased intraocular pressure in the rat retina. Exp Brain Res. 1998;121(4):419-424. (Pubitemid 28370636)
57. Woo Cheon E, Hee Kim Y, Yun Cho Y, et al. Betaxolol, a beta1-adrenoceptor antagonist, protects a transient ischemic injury of the retina. Exp Eye Res. 2002;75(5):591-601. (Pubitemid 35435614)